Shantha Biologics has entered into an outsourcing agreement with Novo Nordisk to provide cartridge fill-finish manufacturing services in India.

The agreement with Novo Nordisk reflects Shantha Biologics' continued focus on high-quality manufacturing execution and its role as a trusted partner to global healthcare companies. The collaboration will be governed by the parties' agreed contractual framework and carried out in accordance with applicable quality, compliance, and regulatory requirements.

Dr. Vishy Chebrol, Director, Shantha Biologics, said, "We are pleased to enter into this collaboration, which reflects the confidence placed in Shantha Biologics' capabilities and our commitment to reliable, high-quality cartridge fill-finish services. We look forward to supporting this partnership through strong operational execution and a continued focus on quality and compliance."

No financial terms or further details of the agreement are being disclosed.